Modeling of Parkinson's disease on D. melanogaster: oxidative stress and the role of isogenization of transgenic lines

  • Kh. A. Dronska
  • Kh. M. Yavdyk
  • O. H. Stasyk
  • N. P. Matiytsiv


Aim. Oxidative stress (OS) is considered one of the main factors that leads to the degeneration of dopamine neurons in Parkinson's disease (PD). The purpose of the work was to test sensitivity to the conditions of the OS of D. melanogaster individuals with expression of human alpha-synuclein in neurons UAS-SNCA/elavGal4; and establish the role of the isogenization of the lines derived from stock collections in the study of this phenotype. Methods. For the isogenyzation of the line, we conducted five generations of sequential crossings of individuals with insertion of human alpha synuclein gene into the w1118 line. A 4-day test using H2O2 as prooxidant was used to test the sensitivity to OS conditions. Results. Individuals with expression of alpha-synuclein gene in neurons were characterized by statistically significant sensitivity to OS conditions, compared with controls. Also, there was a significant difference in the degree of sensitivity to the OS in the second day of the experiment in individuals before and after the isogenization of the effector line. Conclusions. Hypersensitivity to the OS is detected as a specific phenotype under conditions of expression of human alpha-synuclein in Drosophila neurons. The importance of the isogenization of transgenic lines for the characterization of the stress susceptibility phenotype is established.
Keywords: Drosophila melanogaster, alpha-synuclein, oxidative stress, isogenization.


Thomas B., Beal M.F. Parkinson’s disease. Hum. Mol. Genet. 2007. Vol. 16. Р.183–194. doi: 10.1093/hmg/ddm159.

Parkinson’s News Today. Parkinson’s Disease Statistics. URL: (Last accessed: 28.02.2018).

Chaudhuri K.R., Yates L., Martinez-Martin P. The non-motor symptom complex of Parkinson’s disease: a comprehensive assessment is essential. Curr Neurol Neurosci Rep. 2005. Vol. 5. P. 275–283.

Jankovic J. Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008. Vol. 79 (4). P. 368–376. doi: 10.1136/jnnp.2007.131045.

Pan T., Kondo S., Le W., Jankovic J. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson’s disease. Brain. 2009. Vol. 131. P. 1969–1978. doi: 10.1093/brain/awm318.

Ibanez P. et al. Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet. 2004. Vol. 364. Р. 1169–1171. doi: 10.1016/s0140-6736(04)17104-3.

Venda L.L., Cragg S.J., Buchman V.L., Wade-Martins R. α-Synuclein and dopamine at the crossroads of Parkinson’s disease. Trends Neurosci. 2010. Vol. 33 (12). P. 559–568. doi: 10.1016/j.tins.2010.09.004.

Feany M.B., Bender W.W. A Drosophila model of Parkinson’s disease. Nature. 2000. Vol. 404. P. 394–398. doi: 10.1038/35006074

Botella J.A., Bayersdorfer F., Gmeiner F., Schneuwly S. Modelling Parkinson’s Disease in Drosophila. Neuromol Med. 2009. Vol. 12. Р. 268–280. doi: 10.1007/s12017-009-8098-6.

Malkus K.A., Tsika E., Ischiropoulos H. Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson’s disease: how neurons are lost in the Bermida triangle. Mol. Neurodegener. 2009. Vol. 4. P. 4–24. doi: 10.1186/1750-1326-4-24.

Sharma S.K., Babitch J.A. Application of Bradford’s protein assay to chick brain subcellular Fractions. J. Biochem. Biophys. Methods. 1980. Vol. 2 (4). P. 247–250.

Mohylyak I.I., Matiutsiv N.P., Hrunyk N.I., Chernyk Ya.I. Sensitivity of neurodegenerative mutants of Drosophila melanogaster from Swiss cheese group to the oxidative stress conditions. Biopolym. Cell. 2011. Vol. 27(6). P. 453-458. doi: 10.7124/bc.000117

Jahromi S.R., Haddadi M., Shivanandappa T., Ramesh S.R. Attenuation of neuromotor deficits by natural antioxidants of Decalepis hamiltonii in transgenic Drosophila model of Parkinson's disease. Neuroscience. 2015. Vol. 7 (293). P. 136–150. doi: 10.1016/j.neuroscience.